Should Income Investors Look At Ningbo David Medical Device Co., Ltd. (SZSE:300314) Before Its Ex-Dividend?
Should Income Investors Look At Ningbo David Medical Device Co., Ltd. (SZSE:300314) Before Its Ex-Dividend?
Readers hoping to buy Ningbo David Medical Device Co., Ltd. (SZSE:300314) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is usually set to be one business day before the record date which is the cut-off date on which you must be present on the company's books as a shareholder in order to receive the dividend. The ex-dividend date is important because any transaction on a stock needs to have been settled before the record date in order to be eligible for a dividend. Therefore, if you purchase Ningbo David Medical Device's shares on or after the 19th of June, you won't be eligible to receive the dividend, when it is paid on the 19th of June.
如果读者想因股息购买戴维医疗股份有限公司(SZSE:300314),则他们需要尽快采取行动,因为股票即将交易除息。除息日期通常是设置在记录日的前一天,即您必须作为股东在公司名册上登记才能获得股息的截止日期。除息日非常重要,因为任何股票交易必须在记录日之前结算才能有资格获得股息。因此,如果您在6月19日或之后购买戴维医疗股份,则在6月19日支付股息时将无资格获得股息。
The company's next dividend payment will be CN¥0.18 per share. Last year, in total, the company distributed CN¥0.18 to shareholders. Last year's total dividend payments show that Ningbo David Medical Device has a trailing yield of 1.6% on the current share price of CN¥10.97. Dividends are an important source of income to many shareholders, but the health of the business is crucial to maintaining those dividends. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing.
该公司的下一个股息支付金额将为每股人民币0.18元。去年,该公司总计向股东分配了人民币0.18元。去年的总股息支付表明,在每股股价为人民币10.97元的情况下,戴维医疗股份的滚动收益率为1.6%。股息是许多股东的重要收入来源,但业务的健康状况对于维持这些股息至关重要。这就是为什么我们应该始终检查股息支付是否持续,以及公司是否在成长。
If a company pays out more in dividends than it earned, then the dividend might become unsustainable - hardly an ideal situation. That's why it's good to see Ningbo David Medical Device paying out a modest 38% of its earnings. That said, even highly profitable companies sometimes might not generate enough cash to pay the dividend, which is why we should always check if the dividend is covered by cash flow. The company paid out 94% of its free cash flow over the last year, which we think is outside the ideal range for most businesses. Companies usually need cash more than they need earnings - expenses don't pay themselves - so it's not great to see it paying out so much of its cash flow.
如果一家公司支付的股息超过了其所赚取的利润,那么该股息可能会变得不可持续-这绝非理想的情况。这就是为什么看到戴维医疗股份支付了其收益的适度38%是好的。话虽如此,即使是高盈利的公司有时也可能无法产生足够的现金来支付股息,这就是为什么我们应该始终检查股息是否由现金流量支持。该公司过去一年支付了其自由现金流量的94%,我们认为这超出了大多数企业的理想范围。通常,企业需要的是现金,而不是收益-支出不能自己支付-因此看到它支付了如此多的现金流量并不是好的情况。
Ningbo David Medical Device paid out less in dividends than it reported in profits, but unfortunately it didn't generate enough cash to cover the dividend. Cash is king, as they say, and were Ningbo David Medical Device to repeatedly pay dividends that aren't well covered by cashflow, we would consider this a warning sign.
戴维医疗股份支付给股东的股息比其所报告的利润少,但不幸的是它没有产生足够的现金来支付股息。正如他们所说,现金就是王者,如果戴维医疗股份反复支付未被现金流覆盖的股息,我们会认为这是一个预警信号。
Click here to see how much of its profit Ningbo David Medical Device paid out over the last 12 months.
点击此处,查看戴维医疗股份过去12个月的股利支付金额。
![historic-dividend](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240615/0-0a75e94df3feaecf8736b9914bb3c129-0-f494e74e97d5d5280508ae03d2d4eccb.png/big)
Have Earnings And Dividends Been Growing?
收益和股息一直在增长吗?
Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. It's encouraging to see Ningbo David Medical Device has grown its earnings rapidly, up 36% a year for the past five years. Earnings have been growing quickly, but we're concerned dividend payments consumed most of the company's cash flow over the past year.
业务增长迅速的公司通常是最好的股息支付者,因为当每股收益改善时,增加股息就变得更容易。投资者喜欢股息,因此如果收益下降并且派息降低,那么股票将很快被大量抛售。令人鼓舞的是,戴维医疗股份的收益迅速增长,过去五年年均增长36%。收益正在快速增长,但我们担心股息支付消耗了公司过去一年大部分的现金流。
Many investors will assess a company's dividend performance by evaluating how much the dividend payments have changed over time. Ningbo David Medical Device has delivered an average of 15% per year annual increase in its dividend, based on the past 10 years of dividend payments. It's great to see earnings per share growing rapidly over several years, and dividends per share growing right along with it.
许多投资者将评估公司的股息表现,通过评估股息支付金额如何随时间变化而改变。基于过去10年的股息支付,戴维医疗股份年平均股息增长率为15%。很高兴看到每股收益在多年迅速增长,每股股息也在同样增长。
To Sum It Up
总结一下
Should investors buy Ningbo David Medical Device for the upcoming dividend? We like that Ningbo David Medical Device has been successfully growing its earnings per share at a nice rate and reinvesting most of its profits in the business. However, we note the high cashflow payout ratio with some concern. All things considered, we are not particularly enthused about Ningbo David Medical Device from a dividend perspective.
投资者是否应购买即将到来的戴维医疗股份股息?我们喜欢看到戴维医疗股份成功以很好的速度增长每股收益,并将其大部分利润重新投资于业务中。但是,我们需要对高的现金流量支付比率保持警惕。综上所述,从股息角度来看,我们对戴维医疗股份并不特别热衷。
While it's tempting to invest in Ningbo David Medical Device for the dividends alone, you should always be mindful of the risks involved. We've identified 3 warning signs with Ningbo David Medical Device (at least 1 which is significant), and understanding them should be part of your investment process.
虽然仅仅为了股息而投资戴维医疗股份的诱惑很大,但您始终应谨记其中的风险。我们已经确定了戴维医疗股份的3个警告信号(至少有1个非常重要),并且了解它们应该成为您的投资过程的一部分。
Generally, we wouldn't recommend just buying the first dividend stock you see. Here's a curated list of interesting stocks that are strong dividend payers.
一般来说,我们不建议仅仅购买第一个股息股票。下面是一个经过策划的有趣的、股息表现良好的股票清单。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有反馈?关于内容有所顾虑?直接和我们联系。或者,发送电子邮件至editorial-team (at) simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
对本文有反馈?关于内容有所顾虑?直接和我们联系。或者发送电子邮件至editorial-team@simplywallst.com。